Strategic Global Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.64M Buy
25,003
+1,211
+5% +$225K 0.76% 45
2025
Q1
$4.98M Sell
23,792
-580
-2% -$122K 0.99% 33
2024
Q4
$4.33M Buy
24,372
+3,864
+19% +$687K 0.79% 40
2024
Q3
$4.05M Sell
20,508
-221
-1% -$43.6K 0.8% 41
2024
Q2
$3.56M Buy
20,729
+384
+2% +$65.9K 0.74% 42
2024
Q1
$3.7M Sell
20,345
-593
-3% -$108K 0.8% 41
2023
Q4
$3.24M Sell
20,938
-14,568
-41% -$2.26M 0.74% 46
2023
Q3
$5.29M Sell
35,506
-1,872
-5% -$279K 0.88% 37
2023
Q2
$5.04M Sell
37,378
-27,151
-42% -$3.66M 0.77% 48
2023
Q1
$10.3M Sell
64,529
-5,720
-8% -$912K 1.65% 13
2022
Q4
$11.4M Sell
70,249
-17,720
-20% -$2.86M 1.82% 11
2022
Q3
$11.8M Sell
87,969
-3,509
-4% -$471K 1.97% 9
2022
Q2
$14M Buy
91,478
+9,720
+12% +$1.49M 2.14% 7
2022
Q1
$13.3M Buy
81,758
+3,971
+5% +$644K 1.94% 9
2021
Q4
$10.5M Buy
77,787
+6,404
+9% +$867K 1.36% 18
2021
Q3
$7.7M Buy
71,383
+16,839
+31% +$1.82M 1.13% 25
2021
Q2
$6.14M Sell
54,544
-2,976
-5% -$335K 1.12% 22
2021
Q1
$6.23M Buy
57,520
+17,047
+42% +$1.84M 1.12% 22
2020
Q4
$4.34M Sell
40,473
-873
-2% -$93.5K 0.77% 43
2020
Q3
$3.62M Buy
41,346
+3,456
+9% +$303K 0.68% 51
2020
Q2
$3.72M Buy
37,890
+4,070
+12% +$400K 0.8% 40
2020
Q1
$2.58M Buy
33,820
+4,981
+17% +$380K 0.66% 47
2019
Q4
$2.55M Sell
28,839
-266
-0.9% -$23.5K 0.53% 51
2019
Q3
$2.2M Sell
29,105
-2,454
-8% -$186K 0.5% 52
2019
Q2
$2.3M Buy
31,559
+215
+0.7% +$15.6K 0.49% 57
2019
Q1
$2.53M Buy
31,344
+25,037
+397% +$2.02M 0.53% 60
2018
Q4
$581K Buy
6,307
+28
+0.4% +$2.58K 0.21% 90
2018
Q3
$594K Buy
+6,279
New +$594K 0.18% 105
2016
Q2
Sell
-17,572
Closed -$1M 145
2016
Q1
$1M Sell
17,572
-3,735
-18% -$213K 0.43% 76
2015
Q4
$1.26M Sell
21,307
-15,465
-42% -$916K 0.54% 68
2015
Q3
$2M Buy
36,772
+15,993
+77% +$870K 0.96% 36
2015
Q2
$1.4M Buy
20,779
+3,140
+18% +$211K 0.81% 24
2015
Q1
$1.03M Hold
17,639
0.76% 32
2014
Q4
$1.15M Buy
+17,639
New +$1.15M 1.03% 24